Know Cancer

or
forgot password

Nonpharmacologic Analgesia for Invasive Procedures


Phase 2/Phase 3
18 Years
90 Years
Not Enrolling
Both
Pain, Anxiety

Thank you

Trial Information

Nonpharmacologic Analgesia for Invasive Procedures


Inclusion Criteria:



- Patients referred for transcatheter embolization for benign uterine fibroid tumors or
malignant hepatic tumors.

- Patients referred for radiofrequency ablation of malignant hepatic or renal tumors

Exclusion Criteria:

- Unable to give informed consent

- Impaired mental function, psychosis, severe chronic obstructive pulmonary disease,
intolerance towards midazolam or fentanyl

- Weigh < 55 kg

- Pregnant

- Unable to hear or understand English

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Principal Investigator

Elvira V. Lang, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Beth Israel Deaconess Medical Center

Authority:

United States: Federal Government

Study ID:

R01 AT000002

NCT ID:

NCT00010855

Start Date:

September 1997

Completion Date:

April 2007

Related Keywords:

  • Pain
  • Anxiety
  • hypnosis
  • relaxation
  • invasive medical procedures
  • interventional radiology
  • conscious sedation
  • anesthesia
  • complications
  • cost analysis
  • Interventional procedures, complications
  • Angiography
  • Nephrostomy
  • Hepatic chemoembolization
  • Fibroid Embolization
  • Anxiety Disorders

Name

Location

Beth Israel Deaconess Medical CenterBoston, Massachusetts  02215